OGD 2018 Annual Report

Review of the Office of Generic Drugs’ 2018 Annual Report

Leave a Comment / Biopharma / Pharma, CGMP, CQO/SVP Quality/VP Quality, Director/Manager QA, Enforcement Trends, FDAzilla, Highlighted, Human Drugs, Regulatory/Guidance / By

GMP expert Barbara W. Unger reviews the Office of Generic Drugs’ 2018 Annual Report.